In Vitro Inhibition of the Mycobacterium tuberculosis β-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid

The first-line specific antituberculous drug isoniazid inhibits the fatty acid elongation system (FAS) FAS-II involved in the biosynthesis of mycolic acids, which are major lipids of the mycobacterial envelope. The MabA protein that catalyzes the second step of the FAS-II elongation cycle is structu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Ducasse-Cabanot, Stéphanie, Cohen-Gonsaud, Martin, Marrakchi, Hedia, Nguyen, Michel, Zerbib, Didier, Bernadou, Jean, Daffé, Mamadou, Labesse, Gilles, Quémard, Annaíik
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2004
Aiheet:
Mechanisms of Action: Physiological Effects
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC310174/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14693546/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.1.242-249.2004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia